| 产品详情 |
| Edit |   |
|---|
| Product Name | GSK2578215A |
|---|
| Description | Purity ~99% (HPLC). Potent leucine-rich repeat kinase 2 (LRRK2) inhibitor (IC50 values are 8.9 and 10.1nm respectively for LRRK2[G2019S] mutant and wild-type LRRK2 respectively). Displays selectivity for LRRK2 against a panel of 460 other kinases. Blocks Ser910 and Ser935 phosphorylation in vitro and in peripheral tissues in vivo. Brain penetrant. TLC Conditions: Rf = 0.7 (Dichloromethane:Methanol:Ammonia soln. [90:9:1]) Method for Determining Identity: Proton NMR Spectroscopic Analysis and Mass Spectrum Analysis Elemental Analysis: Calculated: %C: 72.17, %H: 4.54, %N: 10.52 Solubility: GSK2578215A is supplied as a crystalline solid. A stock solution may be made by dissolving the GSK2578215A in the solvent of choice. GSK2578215A is soluble in organic solvents such as ethanol, DMSO, and dimethyl formamide (DMF), which should be purged with an inert gas. The solubility of GSK2578215A in ethanol is approximately 1 mg/ml and approximately 10mg/ml in DMSO and DMF. GSK2578215A is sparingly s |
|---|
| Size | 10mg, 25mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 5-(2-Fluoro-4-pyridinyl)-2-(phenylm ethoxy)-N-3-pyridinylbenzamide |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 145675 |
|---|
| Price | |
|---|
| Order / More Info | GSK2578215A from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|